1. O38 Preclinical and clinical characterization of cenerimod, a potent, selective, and orally active sphingosine-1-phosphate receptor 1 modulator in SLE. (23rd March 2020) Authors: Strasser, Daniel S; Gerossier, Estelle; Sippel, Virginie; Grieder, Ursula; Kieninger-Graefitsch, Andrea; Pierlot, Gabin; Farine, Hervé; Kulig, Paulina; Keller, Marcel; Froidevaux, Sylvie; Trendelenburg, Marten; Murphy, Mark; Martinic, Marianne Journal: Lupus science & medicine Issue: Volume 7(2020)Supplement 1 Page Start: A29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P138 Preclinical and clinical characterization of cenerimod, a potent, selective, and orally active sphingosine-1-phosphate receptor 1 modulator in SLE. (23rd March 2020) Authors: Strasser, Daniel S; Gerossier, Estelle; Sippel, Virginie; Grieder, Ursula; Kieninger-Graefitsch, Andrea; Pierlot, Gabin; Farine, Hervé; Kulig, Paulina; Keller, Marcel; Froidevaux, Sylvie; Trendelenburg, Marten; Murphy, Mark; Martinic, Marianne Journal: Lupus science & medicine Issue: Volume 7(2020)Supplement 1 Page Start: A97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗